138 related articles for article (PubMed ID: 7922980)
1. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.
Harada Y; Katagiri T; Ito I; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer; 1994 Oct; 74(8):2281-6. PubMed ID: 7922980
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
Ito I; Yoshimoto M; Iwase T; Watanabe S; Katagiri T; Harada Y; Kasumi F; Yasuda S; Mitomi T; Emi M
Br J Cancer; 1995 Mar; 71(3):438-41. PubMed ID: 7880720
[TBL] [Abstract][Full Text] [Related]
3. Analysis of genetic alterations related to the development and progression of breast carcinoma.
Nagayama K; Watatani M
Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
[TBL] [Abstract][Full Text] [Related]
4. Identification of high-risk breast cancer patients from genetic changes of their tumors.
Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M
Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
[TBL] [Abstract][Full Text] [Related]
6. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of genetic alterations and progression of primary breast cancer.
Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
[TBL] [Abstract][Full Text] [Related]
9. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
Tsuda H; Fukutomi T; Hirohashi S
Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
[TBL] [Abstract][Full Text] [Related]
10. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.
Borg A; Zhang QX; Olsson H; Wenngren E
Genes Chromosomes Cancer; 1992 Nov; 5(4):311-20. PubMed ID: 1283319
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity at different chromosomes in patients with breast cancer].
Deng GR; He LW; Lin BY
Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):31-4, 63-4. PubMed ID: 7913405
[TBL] [Abstract][Full Text] [Related]
15. [Detection of genetic alterations in sporadic breast tumors].
Schmutzler RK; Homann A; Bierhoff E; Wiestler OD; von Daimling A; Krebs D
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():63-7. PubMed ID: 8672929
[TBL] [Abstract][Full Text] [Related]
16. Genetic markers as prognostic indicators in breast cancer.
Wolman SR; Pauley RJ; Mohamed AN; Dawson PJ; Visscher DW; Sarkar FH
Cancer; 1992 Sep; 70(6 Suppl):1765-74. PubMed ID: 1355402
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
[TBL] [Abstract][Full Text] [Related]
20. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
